Evidence map›Paper›PMID 36962140›Full record

ArticlePLOS global public health2021

Characterization of international partnerships in global retinoblastoma care and research: A network analysis.

Hannah Girdler, Kaitlyn Flegg, John Prochaska, Helen Dimaras

Open access · goldFull text read
In one paragraph

Article in PLOS global public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Hannah GirdlerHuman Biology Program, Faculty of Arts & Science, University of Toronto, Toronto, Canada.ORCID https://orcid.org/0000-0001-7295-8670
Kaitlyn FleggDepartment of Ophthalmology and Vision Sciences, The Hospital for Sick Children, Toronto Canada.ORCID https://orcid.org/0000-0001-9606-6298
John ProchaskaDepartment of Preventive Medicine & Community Health, University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America.ORCID https://orcid.org/0000-0003-3369-2843
Helen DimarasDepartment of Ophthalmology and Vision Sciences, The Hospital for Sick Children, Toronto Canada.ORCID https://orcid.org/0000-0003-1164-2001
University of Toronto · CAHospital for Sick Children · CAThe University of Texas Medical Branch at Galveston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Global cooperation is an integral component of global health research and practice. One Retinoblastoma World (1RBW) is a cooperative network of global treatment centers that care for children affected by retinoblastoma. The study aimed to determine the number, scope and nature of collaborations within 1RBW, and uncover how they are perceived to contribute towards improving retinoblastoma outcomes. A cross-sectional, mixed-methods egocentric network analysis was conducted. Treatment centers (n = 170) were invited to complete an electronic survey to identify collaborative activities between their institution (ego), and respective partners (alters). Network maps were generated to visualize connectivity. Key informants (n = 18) participated in semi-structured interviews to add details about the reported collaborations. Interviews were analysed through inductive thematic analysis. Surveys were completed by 56/170 (33%) of 1RBW treatment centers. Collectively, they identified 112 unique alters (80 treatment centers; 32 other organizations) for a total network size of 168 nodes. Most collaborations involved patient referrals, consultations and twinning/capacity building. Interviews identified four main themes: conceptualization of partnership; primary motivation for collaborations; common challenges to collaboration; and benefits to partnership. There is extensive global collaboration to reduce global retinoblastoma mortality, but there is room to expand connectivity through active efforts to include actors located at network peripheries.

Identifiers

PMID36962140
PMCPMC10021644
OpenAlexW4200034927

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read131
identifiers read4
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.